Electrochemical treatment method to reduce voltage delay and cell resistance in lithium/silver vanadium oxide cells
View Patent ↗It is known that reforming implantable defibrillator capacitors at least partially restores and preserves their charging efficiency. An industry-recognized standard is to reform implantable capacitors by pulse discharging the connected electrochemical cell about once every three months throughout the useful life of the medical device. A Li/SVO cell typically powers such devices. The present invention relates to methodologies for significantly minimizing, if not entirely eliminating, the occurrence of voltage delay and irreversible Rdc growth in the about 35% to 70% DOD region by subjecting Li/SVO cells to novel discharge regimes. At the same time, the connected capacitors in the cardiac defibrillator are reformed to maintain them at their rated breakdown voltages.
1. A method for powering an implantable medical device with an electrochemical cell, the cell comprising an alkali metal anode coupled to a cathode of a cathode active material activated with an electrolyte, comprising the steps of:
a) connecting a negative terminal and a positive terminal of the cell to the implantable medical device;
b) powering the implantable medical device with the cell;
c) monitoring the depth-of-discharge (DOD) of the cell; and
d) upon the cell reaching at least about 15% DOD, discharging the cell to deliver capacity equivalent to about 0.2% DOD to about 10% DOD through the application of at least two current pulses separated by a rest period of about one-half to about five seconds.
2. A method for powering an implantable medical device with an electrochemical cell, the cell comprising an alkali metal anode coupled to a cathode of a cathode active material activated with an electrolyte, comprising the steps of:
a) connecting a negative terminal and a positive terminal of the cell to the implantable medical device;
b) powering the implantable medical device with the cell;
c) monitoring the depth-of-discharge (DOD) of the cell;
d) upon the cell reaching about 15% to about 30% DOD, causing the cell to deliver a first current pulse discharge of significantly greater amplitude than that of a pre-pulse current immediately prior to the first current pulse discharge;
e) waiting about one-half to about five seconds; and
f) discharging the cell to deliver a second current pulse discharge of significantly greater amplitude than that of a pre-pulse current immediately prior to the second current pulse discharge, wherein the first and second current pulse discharges remove cumulative capacity equivalent to about 0.2% DOD to about 10% DOD from the cell.
3. The method of claim 2 including discharging the cell to deliver the first current pulse discharge and the second current pulse discharge to the implantable medical device or to a secondary load.
4. The method of claim 2 including discharging the cell to deliver about 20 mA/cm 2 to about 1 amp/cm 2 as the first current pulse discharge and second current pulse discharge.
5. The method of claim 2 including providing the cell of a lithium/silver vanadium oxide couple.
6. A method for providing electrical energy from an electrochemical cell comprising an alkali metal anode coupled to a cathode of a cathode active material activated with an electrolyte, comprising the steps of:
a) connecting a negative terminal and a positive terminal of the cell to a load;
b) powering the load with the cell;
c) upon the cell reaching about 15% depth-of-discharge (DOD) to about 30% DOD, discharging the cell to deliver a first current pulse discharge of significantly greater amplitude than that of a pre-pulse current immediately prior to the first current pulse discharge;
d) waiting about one-half to about five seconds; and
e) discharging the cell to deliver a second current pulse discharge of significantly greater amplitude than that of a pre-pulse current immediately prior to the second current pulse discharge, wherein the first and second current pulse discharges remove cumulative capacity equivalent to about 0.2% DOD to about 10% DOD from the cell.
7. The method of claim 6 including discharging the cell to deliver the first current pulse discharge and the second current pulse discharge to the load being powered by the cell or to a secondary load.
8. The method of claim 6 including discharging the cell to deliver about 20 mA/cm 2 to about 1 amp/cm 2 as the first current pulse discharge and second current pulse discharge.
9. The method of claim 6 including providing the load as an implantable medical device.
10. The method of claim 6 including providing the cathode active material comprising silver vanadium oxide.